J David Cameron
Internal Medicine · Bellevue, WANPI 1447206875
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,748, 6.6 times the $265 reported in 2023. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $28.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$685
- Mayne Pharma Commercial LLC$633
- AbbVie$573
- Dexcom, Inc.$280
- AstraZeneca$252
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$110
- plus $972 from 20 others
What the payments were for
- Food & beverage$3,504100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $685 |
| Mayne Pharma Commercial LLC | 27 | $633 |
| AbbVie | 23 | $573 |
| Dexcom, Inc. | 4 | $280 |
| AstraZeneca | 7 | $252 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $110 |
| Bayer | 4 | $95 |
| Johnson & Johnson | 3 | $95 |
| Exact Sciences | 4 | $93 |
| Bausch Health US, LLC | 3 | $74 |
| Lilly USA, LLC | 3 | $67 |
| Tris Pharma Inc | 3 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Abbott | 2 | $58 |
| Edwards Lifesciences | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| GSK | 2 | $48 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Kowa Pharmaceuticals America, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Medtronic | 1 | $26 |
| Seqirus USA Inc | 1 | $25 |
| Phadia US Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Amgen | 1 | $18 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$136
- AIRSUPRA$126
- Ozempic$125
How this compares
$3,504 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 23 | $8,281 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $874 |
| Fluoxetine Hcl | 31 | $405 |
| Gabapentin | 31 | $370 |
| Atorvastatin Calcium | 40 | $314 |
| Amlodipine Besylate | 42 | $305 |
| Trazodone Hcl | 28 | $225 |
| ClopidogrelClopidogrel Bisulfate | 26 | $208 |
| Ibuprofen | 12 | $179 |
| Metoprolol Succinate | 22 | $176 |
| Losartan Potassium | 17 | $165 |
| Baclofen | 17 | $135 |
| Tamsulosin Hcl | 20 | $119 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $107 |
| Tizanidine Hcl | 14 | $100 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bellevue
- Lawrence LoebBellevue$784K
- Gary SchusterBellevue$16K
- Tatyana KutsyBellevue$13K
- Peter ShalitSeattle$1M
- Shawna PurcellOlympia$294K
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Alan KellySpokane Valley$96K
- Emily EgdaminWenatchee$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.